期刊文献+

烯胺酮与溴代酰胺通过[3+2]环加成构建吡咯烷类化合物

Construction of Pyrrolidine Compounds by [3+2] Cycloaddition of Enaminones and Bromoamides
下载PDF
导出
摘要 吡咯烷是一类具有独特结构的五元含氮杂环化合物,在医药领域应用极其广泛。探究了烯胺酮(1)与溴代酰胺(2)通过[3+2]环加成反应合成多取代吡咯烷类化合物(3a~3p)的方法,通过^(1)HNMR、^(13)CNMR等对其结构进行了表征,并对合成条件进行了优化。结果表明,以1-(苄氧基)-4-苯甲酰基-5-(二甲基氨基)-3,3-二甲基吡咯烷-2-酮(3a)的合成为模型反应,确定最佳合成条件如下:碱为Cs_(2)CO_(3)、碱用量为2.5 eq.、溶剂为CHCl_(3)、0℃冰水浴缓慢转为室温反应,在此条件下,目标化合物3a收率为83%。该合成方法具有原料廉价易得、反应条件温和、操作简单、无需金属催化、对环境影响小等特点。 Pyrrolidine is a kind of five-membered nitrogenous heterocyclic compounds with unique structures,which is widely used in medicine field.We investigated the synthesis of polysubstituted pyrrolidine compounds(3a-3p)by[3+2]cycloaddition reaction between enaminones(1)and bromoamides(2),characterized their structures by^(1)HNMR and^(13)CNMR,and optimized the synthesis conditions.The results show that,by using the synthesis of 1-(benzyloxy)-4-benzoyl-5-(dimethylamino)-3,3-dimethylpyrrolidine-2-one(3a)as a model reaction,the optimal synthesis conditions can be determined as follows:Cs_(2)CO_(3)is adopted as the base,the amount of base is 2.5 eq.,the solvent is CHCl_(3),and ice water bath at 0℃slowly converting to room temperature reaction is adopted.Under above conditions,the yield of the target compound 3a is 83%.The synthesis method has the characteristics of cheap raw materials,mild reaction conditions,simple operation,metal-free catalysis,and little environmental impact.
作者 王青青 袁成 孙绍发 汪钢强 WANG Qingqing;YUAN Cheng;SUN Shaofa;WANG Gangqiang(School of Pharmacy,Hubei University of Science and Technology,Xianning 437100,China;School of Nuclear Technology and Chemistry&Biology,Hubei University of Science and Technology,Xianning 437100,China)
出处 《化学与生物工程》 CAS 北大核心 2024年第5期44-50,共7页 Chemistry & Bioengineering
基金 国家自然科学基金面上项目培育计划项目(82173713) 国家级大学生创新创业训练计划项目(202110927009)。
关键词 含氮杂环化合物 烯胺酮 溴代酰胺 吡咯烷类化合物 [3+2]环加成 nitrogenous heterocyclic compound enaminone bromoamide pyrrolidine compound [3+2]cycloaddition
  • 相关文献

参考文献8

二级参考文献78

  • 1丁爱石,王福庄.新生大鼠海马神经元在无血清培养液中的生长特性[J].细胞生物学杂志,1993,15(2):88-90. 被引量:82
  • 2蒋祝昌,毕桂南,石胜良.黄皮酰胺对高血压局灶性脑缺血-再灌注大鼠Bcl-2蛋白表达和细胞凋亡的影响[J].中国危重病急救医学,2005,17(5):289-292. 被引量:18
  • 3Neuner EA,Ritchie DJ,Micek ST,et al. New antibiotics for healthcare -associate Pneumonia[ J]. Semin Respir Crit Care Med,2009 ; 30:92 - 101.
  • 4Deresinski SC. Ceftobiprole : breaking therapeutic dogmas of the β - lactam class [ J ]. Diagn Microbiol Infect Disease, 2008 ;61:82 - 85.
  • 5Yun HC, Ellis WM, Jorgensen JH, Activity of ceftobiprole against community - assosiated methicillin - resistant S. aureus isolates recently recovered from US military trainees[ J]. Diagn Microbiol Infect Disease, 2007 ;57:463 -466.
  • 6Goldstein E J, Citron DM, Merriam CV, et al. In vitro activity of ceftobiprole against anaerobic strains isolated from diabetic foot infections [ J ]. A ntimicrob Agents Chemother, 2006:50:3959 - 3962.
  • 7Wootton M, Bower KE, Holt HA, et al. BAL -9141, a new broad -spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparision with 10 other antimicrobials [ J]. J Antimicrob Chemother, 2002:49:535 -539.
  • 8Noel GJ, Bush K, Bagchi P, et al. A randomized double - blind trial comparing ceftobiprole medocarial with vancomycin plus ceftazi- dime for the treatment of patient with complicated skin and skin structure infectious[ J ]. Clin Infect Dis, 2008 ;46:647 - 655.
  • 9Widmer AF. Ceftobiprole: A new option for treatment of skin and soft - tissue infections due to methicillin - resistant Stophylococcus aureus[ J ]. Clin Infect Dis, 2008; 46:656 -658.
  • 10Deresinski SC. The efficacy and safety of ceftobiprole in the treatment of complicateskin and skin structure infections : evidence from 2 clinical trials[ J]. Diagn Microbiol Infect Disease, 2008 ;61 : 103 - 109.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部